57 related articles for article (PubMed ID: 25130069)
1. High preoperative C-reactive protein values predict poor survival in patients on chronic hemodialysis undergoing nephrectomy for renal cancer.
Omae K; Kondo T; Tanabe K
Urol Oncol; 2015 Feb; 33(2):67.e9-13. PubMed ID: 25130069
[TBL] [Abstract][Full Text] [Related]
2. Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients.
Steffens S; Köhler A; Rudolph R; Eggers H; Seidel C; Janssen M; Wegener G; Schrader M; Kuczyk MA; Schrader AJ
BMC Cancer; 2012 Sep; 12():399. PubMed ID: 22958305
[TBL] [Abstract][Full Text] [Related]
3. High CRP values predict poor survival in patients with penile cancer.
Steffens S; Al Ghazal A; Steinestel J; Lehmann R; Wegener G; Schnoeller TJ; Cronauer MV; Jentzmik F; Schrader M; Kuczyk MA; Schrader AJ
BMC Cancer; 2013 May; 13():223. PubMed ID: 23642165
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory response markers and survival prediction in patients with renal cell carcinoma.
Mountzias A; Hultdin J; Hlodan J; Kröger Dahlin BI; Johansson M; Ljungberg B
Scand J Urol; 2022 Feb; 56(1):47-52. PubMed ID: 34586034
[TBL] [Abstract][Full Text] [Related]
5. Early post-operative serum albumin level predicts survival after curative nephrectomy for kidney cancer: a retrospective study.
Tang Y; Liu Z; Liang J; Zhang R; Wu K; Zou Z; Zhou C; Zhang F; Lu Y
BMC Urol; 2018 Dec; 18(1):111. PubMed ID: 30522461
[TBL] [Abstract][Full Text] [Related]
6. Association between Serum C-Reactive Protein Concentrations and Risk of Cancer-Related Mortality in Patients Undergoing Hemodialysis: 10-Year Outcomes of the Q-Cohort Study.
Uchida Y; Nakano T; Hiyamuta H; Kitamura H; Taniguchi M; Ooboshi H; Tsuruya K; Kitazono T
Blood Purif; 2023; 52(7-8):694-701. PubMed ID: 37331339
[TBL] [Abstract][Full Text] [Related]
7. Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC Registry.
Saitta C; Afari JA; Patil D; Tanaka H; Yuen KL; Wang L; Cortes J; Liu F; Mahmood M; Matian J; Mansour M; Puri D; Cerrato C; Nguyen MV; Hakimi K; Kobayashi M; Fukuda S; Meagher MF; Fujii Y; Master V; Derweesh IH
Clin Genitourin Cancer; 2024 Apr; 22(3):102098. PubMed ID: 38733897
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer.
Andersen HH; Bojesen SE; Johansen JS; Ejlertsen B; Berg T; Tuxen M; Madsen K; Danø H; Flyger H; Jensen MB; Nielsen DL
Cancer Epidemiol Biomarkers Prev; 2024 May; 33(5):662-670. PubMed ID: 38358318
[TBL] [Abstract][Full Text] [Related]
9. Association of grit and overall survival in patients undergoing nephrectomy for renal cell carcinoma.
Midenberg ER; Schmeusser BN; Palacios A; Larsen K; Patil DH; Petrinec B; Croll B; Le TL; Hong G; Lin FR; Jesson K; Lee G; Kwon FY; Ogan K; Master VA
Transl Androl Urol; 2022 Nov; 11(11):1503-1511. PubMed ID: 36507475
[TBL] [Abstract][Full Text] [Related]
10. The Relationship Between C-Reactive Protein (CRP) Concentrations and Erythropoietin Resistance, Hospital Admission Rate, Control of Mineral Metabolism, and Comorbidity in Hemodialysis Patients.
Alsogair R; Altoub HA; Alsanad M; Alshukr M; AlObaid B; Al Sayyari A; Abdalla M
Cureus; 2023 Nov; 15(11):e48793. PubMed ID: 38098917
[TBL] [Abstract][Full Text] [Related]
11. Serum C-reactive protein is an important and powerful prognostic biomarker in most adult solid tumors.
Shrotriya S; Walsh D; Nowacki AS; Lorton C; Aktas A; Hullihen B; Benanni-Baiti N; Hauser K; Ayvaz S; Estfan B
PLoS One; 2018; 13(8):e0202555. PubMed ID: 30138391
[TBL] [Abstract][Full Text] [Related]
12. On-treatment risk model for predicting treatment response in advanced renal cell carcinoma.
Guer M; Janitzky A; Schostak M
World J Urol; 2023 Oct; 41(10):2735-2742. PubMed ID: 37552264
[TBL] [Abstract][Full Text] [Related]
13. Impact of preoperative body composition in patients with renal cell carcinoma submitted to surgical treatment.
Carniatto LN; Bitencourt AGV; Miola TM; Agnello J; Xavier CM; da Costa WH
Radiol Bras; 2023; 56(6):317-320. PubMed ID: 38504815
[TBL] [Abstract][Full Text] [Related]
14. Measuring quality care in localized renal cell cancer: use of appropriate preoperative investigations in a population-based cohort.
Moideen N; Marzouk KH; Matheson KJ; Wood LA
Curr Oncol; 2017 Apr; 24(2):e152-e156. PubMed ID: 28490939
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Risk Stratification of Renal Neoplasia: Are Classification Semantics Hindering Progress?
McKenney JK
Eur Urol; 2024 Jan; 85(1):72-73. PubMed ID: 37858452
[No Abstract] [Full Text] [Related]
16. Clinical symptoms predict poor overall survival in chronic-dialysis patients with renal cell carcinoma associated with end-stage renal disease.
Ikezawa E; Kondo T; Hashimoto Y; Kobayashi H; Iizuka J; Takagi T; Omae K; Tanabe K
Jpn J Clin Oncol; 2014 Nov; 44(11):1096-100. PubMed ID: 25139162
[TBL] [Abstract][Full Text] [Related]
17. Increased level of serum leucine-rich-alpha-2-glycoprotein 1 in patients with clear cell renal cell carcinoma.
Nakanishi S; Goya M; Suda T; Yonamine T; Sugawa A; Saito S
BMC Urol; 2024 Apr; 24(1):94. PubMed ID: 38658967
[TBL] [Abstract][Full Text] [Related]
18. Postoperative C-reactive protein-to-albumin ratio predicts poor prognosis in patients with bladder cancer undergoing radial cystectomy.
Kuroda K; Tasaki S; Horiguchi A; Ito K
Mol Clin Oncol; 2021 Mar; 14(3):54. PubMed ID: 33604044
[TBL] [Abstract][Full Text] [Related]
19. C-Reactive Protein and Cancer-Diagnostic and Therapeutic Insights.
Hart PC; Rajab IM; Alebraheem M; Potempa LA
Front Immunol; 2020; 11():595835. PubMed ID: 33324413
[TBL] [Abstract][Full Text] [Related]
20. Impact of Percent Body Fat on All-Cause Mortality among Adequate Dialysis Patients with and without Insulin Resistance: A Multi-Center Prospective Cohort Study.
Duong TV; Wong TC; Chen HH; Chen TH; Hsu YH; Peng SJ; Kuo KL; Liu HC; Lin ET; Yang SH
Nutrients; 2019 Jun; 11(6):. PubMed ID: 31181824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
